Inclusion-Cell (I-Cell) Disease (Mucolipidosis Type II) Medication

Updated: Apr 01, 2021
  • Author: Karl S Roth, MD; Chief Editor: Luis O Rohena, MD, PhD, FAAP, FACMG  more...
  • Print
Medication

Medication Summary

Drug therapy is not currently a component of the standard of care in lysosomal storage disorder.